Juul Labs, Inc.

The Juul Labs MDL, centralized in October 2019 around claims that the company's vaping products were marketed to underage users while understating nicotine-addiction and health risks, has been substantially de-risked by a series of large settlements over the past several years — a multistate settlement over youth-marketing practices, a broad class settlement resolving a large share of the consolidated personal-injury and consumer claims, and additional state-level settlements resolving further claim categories. The docket's current pending-action count of eleven reflects that history: this is now a residual docket rather than one with a large, unresolved inventory.

For a funder, that changes the calculus considerably from where this docket stood in its earlier, high-volume years. A remaining Juul-related claim today is most likely one that fell outside the settled tracks — a party that did not participate in the class settlement, a claim filed after key settlement cutoffs, or a claim brought by an entity (such as a school district or a state that did not settle) pursuing a distinct theory of harm. Diligence should focus specifically on why a given claim sits outside the resolved population and what litigation posture it occupies as a result.

Medical-lien considerations are relevant for personal-injury claims tied to nicotine addiction or related respiratory injury, though the practical financing question in this docket is less about lien structuring and more about confirming a claim's eligibility status relative to the settled tracks before sizing any advance.

Given how substantially this docket has already resolved through settlement, single-claim evaluation is the appropriate approach for what remains rather than portfolio-scale inventory finance built around volume this docket no longer has at the MDL level. Criterica Capital's mass-tort finance line applies to any surviving personal-injury claim evaluated on its specific facts.

Criterica Intelligence's structural brief covers how the settled and unsettled claim tracks in this docket diverged.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.